We ask you to participate in a Karolinska Institute survey on the management of severe chemotherapy-induced diarrhea (CID). We would greatly appreciate your help to draw a broader picture of the current international treatment practices. This survey is primarily directed at physicians who are involved in the management of systemic cancer therapies.
It will take less than 10 minutes to complete the survey. Participation is voluntary and your anonymity is guaranteed.
Please forward the survey to anyone you know who is involved in the management of chemotherapy-induced diarrhea.
Acute chemotherapy-induced diarrhea (CID) is a common clinical problem in cancer patients, but its extent in routine care is generally not well described and studies on CID treatment are lacking. CID is physically painful, socially debilitating, and can lead to serious complications such as sepsis. Severe cases require hospital admission, which can delay or preclude oncological treatment. CID also inflicts substantial costs on the health care system. Although a common and highly relevant problem in clinical practice, there is only a weak consensus on the important aspects of managing severe CID in an in-patient setting.
Maximilian Kordes and Marco Gerling
Dept. of Cancer | Karolinska University Hospital